Components:
Medically reviewed by Fedorchenko Olga Valeryevna, PharmD. Last updated on 26.06.2023

Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
An analog of deoxyuridine that inhibits viral DNA synthesis. The drug is used as an antiviral agent. [PubChem]
Ophthalmic
Herpes simplex keratitis
Adult: As 0.1% soln: Instill 1 drop in the affected eye(s) every hr. Taper to every 2 hr or 4 times daily. Continue treatment for at least 7 days.
Topical/Cutaneous
Cutaneous herpes simplex and herpes zoster
Adult: As 5% preparation: Paint onto the lesions 4 times daily for 4 days.
Ophthalmic
Herpes simplex keratitis
Adult: As 0.1% soln: Instill 1 drop in the affected eye(s) every hr. Taper to every 2 hr or 4 times daily. Continue treatment for at least 7 days.
Topical/Cutaneous
Cutaneous herpes simplex and herpes zoster
Adult: As 5% preparation: Paint onto the lesions 4 times daily for 4 days.
Patients at risk of developing resp failure. During an acute attack. Patients receiving MAOI or for 2 wk after discontinuing them. Persistent or chronic cough.
Toxil is used to treat viral infections (keratitis) in the eye caused by herpes simplex.
Other medicines - Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary.
When you are using Toxil, it is especially important that your health care professional know if you are using the following: Eye product containing boric acid. Boric acid may interact with the Toxil preparation causing a gritty substance to form or may interact with the preservative in the Toxil preparation causing a toxic effect in the eye.
Acute ocular irritation including burning, corneal stippling, vascularization, and clouding has been reported. Following prolonged use of Toxil, ocular irritation characterized by follicular conjunctivitis, blepharitis with punctal swelling, bulbar conjunctival hyperemia, and corneal epithelial staining has also been reported. In either case, the drug should be discontinued.